| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030078 |
| Receipt No. | R000034339 |
| Scientific Title | Palliative care research as a whole person approach in comprehensive medical care internal medicine |
| Date of disclosure of the study information | 2017/11/22 |
| Last modified on | 2020/02/21 (Ver. 8) |
| Basic information | ||
| Public title | Palliative care research as a whole person approach in comprehensive medical care internal medicine | |
| Acronym | Palliative care by comprehensive internal medicine | |
| Scientific Title | Palliative care research as a whole person approach in comprehensive medical care internal medicine | |
| Scientific Title:Acronym | Palliative care by comprehensive internal medicine | |
| Region |
|
|
| Condition | |||||||||
| Condition | General medical disorder at the terminal stage | ||||||||
| Classification by specialty |
|
||||||||
| Classification by malignancy | Malignancy | ||||||||
| Genomic information | NO | ||||||||
| Objectives | |
| Narrative objectives1 | Symptomatic relief and mental stability |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Symptom control score
Evaluation every 2 weeks |
| Key secondary outcomes | Questionnaire survey on spiritual stability of the person and family |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Consent from the patient or family | |||
| Key exclusion criteria | Did not obtain consent | |||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | saitama medical university | ||||||
| Division name | Department of General Internal Medicine | ||||||
| Zip code | 350-0495 | ||||||
| Address | 38 Morohongo Moroyama-machi Iruma-gun Saitama, Japan | ||||||
| TEL | 049-276-1667 | ||||||
| guchan@saitama-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saitama Medical University | ||||||
| Division name | Department of General Internal Medicine | ||||||
| Zip code | 350-0495 | ||||||
| Address | 38 Morohongo Moroyama-machi Iruma-gun Saitama, Japan | ||||||
| TEL | 049-276-1111 | ||||||
| Homepage URL | |||||||
| guchan@saitama-med.ac.jp | |||||||
| Sponsor | |
| Institute | Saitama Medical University
Department of General Internal Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saitama Medical University
Department of General Internal Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board in Saitama medical university hospital |
| Address | 38 Morohongo Moroyama-machi Iruma-gun Saitama, Japan |
| Tel | 049-276-1354 |
| 049-276-1354 | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 埼玉医科大学病院(埼玉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Patient satisfaction is high due to intervention of palliative care team on symptom control of terminal chronic disease. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034339 |